Management of Psoriasis through panchakarma

EFFECT OF SHODHANA KARMA (VAMANA FOLLOWED BY VIRECHANA) IN THE MANAGEMENT OF PSORIASIS AND ITS IMPACT ON IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS ?- AN EXPLORATORY STUDY

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037687

Enrollment

Registered

2021-10-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: rookshan snehapana vamana samsarjna karma snehapana virechana samsarjana karma: Rookshana: Sarvanga Dhara will be done by Aargvadha Patra + Haridra Kashaya for 30 mins daily along with

Eligibility

Inclusion criteria

Inclusion criteria: PASI Score: > 10 Moderate to severe Chronicity: up to10 years Patients having the clinical features of Psoriasis (Kitibha Kushtha).

Exclusion criteria

Exclusion criteria: Chronicity of more than 10 years PASI score Patients with Severe Systemic disorders Pregnant women and lactating mothers Patients unfit for Rookshana Snehana, Swedana,Vamana and Virechana Karma

Design outcomes

Primary

Measure	Time frame
1.Change in Immunological and inflammatory Biomarkers. 2.Symptomatic Relief in signs and symptoms of Psoriasis 3.Reduction in Psoriasis Area and Severity Index (PASI) Score. Timepoint: 0th,23rd,40th,80th	—

Secondary

Measure	Time frame
Improvement in DLQI quality of lifeTimepoint: 0th,23rd,40th,80th	—

Countries

India

Contacts

Public ContactDr Latika

All India Institute of Ayurveda

dr.ananthramsharma@gmail.com9495130595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026